SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-050496
Filing Date
2009-10-15
Accepted
2009-10-15 08:02:30
Documents
5
Period of Report
2009-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c91116e8vk.htm 8-K 36958
2 EXHIBIT 2.1 c91116exv2w1.htm EX-2.1 448087
3 EXHIBIT 99.1 c91116exv99w1.htm EX-99.1 31161
4 EXHIBIT 99.2 c91116exv99w2.htm EX-99.2 33326
5 EXHIBIT 99.3 c91116exv99w3.htm EX-99.3 22728
  Complete submission text file 0000950123-09-050496.txt   573807
Mailing Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080
Business Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26483 | Film No.: 091120387
SIC: 2834 Pharmaceutical Preparations